1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 12 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2003Multiple myeloma-derived pro-inflammatory cytokines enhance osteoclastogenesis by increasing the number of RANKL-expressing STRO-1 positive osteoprogenitor cellsPan, B.; To, L.; Farrugia, A.; Kostakis, P.; Atkins, G.; Findlay, D.; Zannettino, A.
2003Receptor activator of nuclear factor-kB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivoFarrugia, A.; Atkins, G.; To, L.; Pan, B.; Horvath, N.; Kostakis, P.; Findlay, D.; Bardy, P.; Zannettino, A.
2017HIF-2α promotes dissemination of plasma cells in multiple myeloma by regulating CXCL12/CXCR4 and CCR1Vandyke, K.; Zeissig, M.; Hewett, D.; Martin, S.; Mrozik, K.; Cheong, C.; Diamond, P.; To, L.; Gronthos, S.; Peet, D.; Croucher, P.; Zannettino, A.
2019Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stabilityDutta, A.; Fink, J.; Grady, J.; Morgan, G.; Mullighan, C.; To, L.; Hewett, D.; Zannettino, A.
2015The effect of the PI3K inhibitor BKM120 on tumour growth and osteolytic bone disease in multiple myelomaMartin, S.; Gan, Z.; Fitter, S.; To, L.; Zannettino, A.
2015Tetraspanin 7 (TSPAN7) expression is upregulated in multiple myeloma patients and inhibits myeloma tumour development in vivoCheong, C.; Chow, A.; Fitter, S.; Hewett, D.; Martin, S.; Williams, S.; To, L.; Zannettino, A.; Vandyke, K.
2013Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myelomaVandyke, K.; Chow, A.; Williams, S.; To, L.; Zannettino, A.
2004The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitroPan, B.; To, L.; Farrugia, A.; Findlay, D.; Green, J.; Gronthos, S.; Evdokiou, A.; Lynch, K.; Atkins, G.; Zannettino, A.
2004Angiogenesis in multiple myeloma: Implications in myeloma therapyMartin, S.; To, L.; Horvath, N.; Zannettino, A.
2006Tumor angiogenesis is associated with plasma levels of stromal-derived factor-1α in patients with multiple myelomaMartin, S.; Dewar, A.; Farrugia, A.; Horvath, N.; Gronthos, S.; To, L.; Zannettino, A.

Discover